NCT07083856 Effects of Reiki and Self-Acupressure Applications
| NCT ID | NCT07083856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Firat University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-20 |
| Primary Completion | 2025-07-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-04-20 with a primary completion date of 2025-07-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.
Eligibility Criteria
Inclusion Criteria: 1. Patients who are willing to participate 2. Patients who have no communication problems 3. Patients who are 18 years of age or older 4. Patients who live in the center 5. Patients who have no scratches or deformities in the treatment area 6. Patients who do not smoke, use drugs, or use tranquilizers, and are not pregnant 7. Patients who have been receiving MS treatment for more than three months Exclusion Criteria: 1. Patients who smoke, use substances, or use tranquilizers 2. Have dyspnea 3. Have anemia 4. Have diabetes 5. Have received corticosteroid treatment in the last three months 6. Have had an MS attack in the last three months 7. Have an autoimmune disease other than multiple sclerosis 8. Have signs of infection 9. Have a thyroid problem 10. Are taking psychostimulant medications 11. Have anxiety or depression detected in outpatient clinic screenings 12. Refuse to participate in the study 13. Have another known neurological system disease (dementia, Alzheimer's, etc.) 14. Have a communication barrier will not be included in the study.
Contact & Investigator
Caner F Demir, MD
STUDY CHAIR
Firat University
Frequently Asked Questions
Who can join the NCT07083856 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07083856 currently recruiting?
Yes, NCT07083856 is actively recruiting participants. Contact the research team at fzt.furkanbilek@gmail.com for enrollment information.
Where is the NCT07083856 trial being conducted?
This trial is being conducted at Muğla, Turkey (Türkiye).
Who is sponsoring the NCT07083856 clinical trial?
NCT07083856 is sponsored by Firat University. The principal investigator is Caner F Demir, MD at Firat University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.